EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data

Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Iván Valdés-Ferrer, Carlos A Fermín-Martínez, Luisa Fernández-Chirino, Arsenio Vargas-Vázquez, Daniel Ramírez-García, Javier Mancilla-Galindo, Ashuin Kammar-García, José Alberto Ávila-Funes, Clemente Humberto Zúñiga-Gil, Miguel García-Grimshaw und 9 weitere

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.01.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Omar Yaxmehen Bello-Chavolla und 20 weiteren Autor:innen. Beteiligte Einrichtung: Dirección de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico. Electronic address: oyaxbell@yahoo.com.mx. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Vaccination has been effective in ameliorating the impact of COVID-19. Here, we report vaccine effectiveness (VE) of the nationally available COVID-19 vaccines in Mexico. METHODS: Retrospective analysis of a COVID-19 surveillance system to assess the VE of the BNT162b2, messenger RNA (mRNA)-12732, Gam-COVID-Vac, Ad5-nCoV, Ad26.COV2.S, ChAdOx1, and CoronaVac vaccines against SARS-CoV-2 infection, COVID-19 hospitalization, and death in Mexico. The VE was estimated using time-varying Cox proportional hazard models in vaccinated and unvaccinated adults, adjusted for age, sex, and comorbidities. VE was also estimated for adults with diabetes, aged ≥60 years, and comparing the predominance of SARS-CoV-2 variants B.1.1.519 and B.1.617.2. RESULTS: We assessed 793,487 vaccinated and 4,792,338 unvaccinated adults between December 24, 2020 and September 27, 2021. The VE against SARS-CoV-2 infection was the highest for fully vaccinated individuals with mRNA-12732 (91.5%, 95% confidence interval [CI] 90.3-92.4) and Ad26.COV2.S (82.2%, 95% CI 81.4-82.9); for COVID-19 hospitalization, BNT162b2 (84.3%, 95% CI 83.6-84.9) and Gam-COVID-Vac (81.4% 95% CI 79.5-83.1), and for mortality, BNT162b2 (89.8%, 95% CI 89.2-90.2) and mRNA-12732 (93.5%, 95% CI 86.0-97.0). The VE decreased for all vaccines in adults aged ≥60 years, people with diabetes, and periods of Delta variant predominance. CONCLUSION: All the vaccines implemented in Mexico were effective against SARS-CoV-2 infection, COVID-19 hospitalization, and death. Mass vaccination with multiple vaccines is useful to maximize vaccination coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdultHumansCOVID-19 VaccinesBNT162 VaccineAd26COVS1MexicoRetrospective StudiesSARS-CoV-2VaccinationHospitalizationRNA, MessengerVaccines, Inactivated

Stichwörter der Autor:innen

COVID-19HospitalizationMortalitySARS-CoV-2Vaccine effectiveness

Substanzen

COVID-19 VaccinesBNT162 VaccineAd26COVS1RNA, Messengersinovac COVID-19 vaccineVaccines, Inactivated

Autor:innen und Institutionen

  • Dirección de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico. Electronic address: oyaxbell@yahoo.com.mx.
  • Dirección de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico; MD/PhD (PECEM) Program, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Dirección de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico; Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • MD/PhD (PECEM) Program, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Dirección de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico; Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.

Zitieren

APA

Bello-Chavolla, O. Y., Antonio-Villa, N. E., Valdés-Ferrer, S. I., Fermín-Martínez, C. A., Fernández-Chirino, L., Vargas-Vázquez, A., Ramírez-García, D., Mancilla-Galindo, J., Kammar-García, A., Ávila-Funes, J. A., Zúñiga-Gil, C. H., García-Grimshaw, M., Ceballos-Liceaga, S. E., Carbajal-Sandoval, G., Montes-González, J. A., Zaragoza-Jiménez, C. A., García-Rodríguez, G., Cortés-Alcalá, R., Reyes-Terán, G., …, & Gutiérrez-Robledo, L. M. (2023). Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.01.040

Vancouver

Bello-Chavolla OY, Antonio-Villa NE, Valdés-Ferrer SI, Fermín-Martínez CA, Fernández-Chirino L, Vargas-Vázquez A, et al. Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.01.040

BibTeX
@article{BelloChavolla2023,
  author = {Bello-Chavolla, Omar Yaxmehen and Antonio-Villa, Neftali Eduardo and Valdés-Ferrer, Sergio Iván and Fermín-Martínez, Carlos A and Fernández-Chirino, Luisa and Vargas-Vázquez, Arsenio and Ramírez-García, Daniel and Mancilla-Galindo, Javier and Kammar-García, Ashuin and Ávila-Funes, José Alberto and Zúñiga-Gil, Clemente Humberto and García-Grimshaw, Miguel and Ceballos-Liceaga, Santa Elizabeth and Carbajal-Sandoval, Guillermo and Montes-González, José Antonio and Zaragoza-Jiménez, Christian Arturo and García-Rodríguez, Gabriel and Cortés-Alcalá, Ricardo and Reyes-Terán, Gustavo and López-Gatell, Hugo and Gutiérrez-Robledo, Luis Miguel},
  title = {Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.01.040}
}
Kostenlos starten →